Strategic Partnerships Nushama has active partnerships with Awakn Life Sciences to deploy the KARE protocol for alcohol use disorder and with Relationship Resources for ketamine-assisted mindfulness retreats, presenting opportunities to co-market and scale new psychedelic treatment programs.

Clinical Expansion With current clinics in New York City, Rockland County, and Miami, there is potential to upsell or expand services to neighboring regions or partner clinics, leveraging existing medical supervision and evidence-led protocols.

Tech & Ops A tech stack including AWS, Shopify, and marketing platforms (Klaviyo, Sendinblue, Mailgun) indicates readiness for scalable patient onboarding, e-commerce for services or memberships, and data-driven outreach.

Market Position Operating in a high-growth psychedelic wellness market with strong clinical outcomes (e.g., Awakn’s efficacy data) positions Nushama to engage enterprise health plans, clinics, and wellness platforms seeking vetted ketamine and Spravato-based interventions.

Financial Upsell Revenue range of 1M–10M and a relatively small team (11–50 employees) suggests budget flexibility for strategic partnerships, co-funding clinical studies, or exploring white-label program licensing and regional expansion.